Jens-Erik Beck Jensen

Jens-Erik Beck Jensen

    Member of:

    • Internal Medicine: Endocrinology


    Publication year:
    All
    1 - 2 out of 2Page size: 10
    1. 2024
    2. Published

      Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial

      Jensen, Simon Birk Kjær, Sørensen, V., Sandsdal, Rasmus Michael, Lehmann, E. W., Lundgren, J. R., Juhl, C. R., Janus, C., Ternhamar, T., Stallknecht, Bente Merete, Holst, Jens Juul, Jørgensen, Niklas Rye, Jensen, Jens-Erik Beck, Madsbad, Sten & Torekov, Signe Sørensen, 2024, In: JAMA network open. 7, 6, 13 p., e2416775.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Cancer risk in patients treated with denosumab compared with alendronate: A population-based cohort study

      Yahyavi, S. K., Holt, R., Knudsen, N. K., Andreassen, C. H., Sejling, Christoffer, Meddis, Alessandra, Kjær, Susanne Krüger, Schwarz, Peter, Jensen, Jens-Erik Beck, Torp-Pedersen, Christian, Juul, Anders, Selmer, Christian & Blomberg Jensen, M., 2024, In: Bone. 182, 8 p., 117053.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 10882847